
Region:North America
Product Code:GDPH4235D
October 2018
40
Summary
BioDelivery Sciences International Inc (BDSI) is a specialty pharmaceutical company which develops and commercializes products in the areas of addiction medicine and pain management. The company's marketed products include fentanyl buccal soluble solution for breakthrough cancer pain; buprenorphine/naloxone buccal film for opioid dependence; and buprenorphine buccal film for chronic pain. Its pipeline encompasses indications targeted at the treatment of chronic pain and opioid dependence. BDSI employs its proprietary BioErodible MucoAdhesive (BEMA) technology which comprises small, bioerodible polymer film used to facilitate rapid delivery a drug across the mucous membranes for time sensitive conditions. BDSI is headquartered in Raleigh, North Carolina, the US.
BioDelivery Sciences International Inc (BDSI)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
BioDelivery Sciences International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BioDelivery Sciences International Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
BioDelivery Sciences International Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BioDelivery Sciences International Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
BioDelivery Sciences International Inc, Medical Devices Deals, 2012 to YTD 2018 9
BioDelivery Sciences International Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
BioDelivery Sciences International Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
BioDelivery Sciences Enters into Co-Development Agreement with Evonik 11
Licensing Agreements 12
Purdue Pharma (Canada) Enters into Licensing Agreement with BioDelivery Sciences International 12
BioDelivery Sciences Enters Into Licensing Agreement With Arcion For Topical Clonidine Gel 13
Equity Offering 15
BioDelivery Sciences Raises USD50 Million Private Placement of Preferred Shares 15
BioDelivery Sciences Completes Private Placement Of Shares For USD 60 Million 17
BioDelivery Sciences Completes Public Offering Of Common Stock And Prferred Stock For USD 40 Million 18
BioDelivery Sciences International Inc-Key Competitors 20
BioDelivery Sciences International Inc-Key Employees 21
BioDelivery Sciences International Inc-Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Financial Announcements 23
Aug 09, 2018: BioDelivery Sciences reports strong second quarter 2018 financial results 23
May 10, 2018: BioDelivery Sciences Reports Positive First Quarter 2018 Financial Results and Provides Corporate Update 24
Mar 16, 2018: BioDelivery Sciences Announces Fourth Quarter and Full-Year 2017 Financial Results 25
Nov 09, 2017: BioDelivery Sciences Reports Third Quarter 2017 Financial Results and Provides Corporate Update 27
Aug 09, 2017: BioDelivery Sciences Reports Second Quarter 2017 Financial Results and Provides Corporate Update 29
May 15, 2017: BioDelivery Sciences Reports First Quarter 2017 Financial Results and Provides Corporate Update 32
Mar 17, 2017: BioDelivery Sciences Provides Corporate Update and Reports Fourth Quarter and Full-Year 2016 Financial Results 34
Corporate Communications 37
Jul 30, 2018: BioDelivery Sciences appoints Thomas Smith, MD as chief medical officer further expanding company's expertise in field of pain management 37
May 07, 2018: BioDelivery Sciences Names Herm Cukier As Chief Executive Officer 38
Aug 23, 2017: BioDelivery Sciences President and Chief Executive Officer Dr. Mark A. Sirgo to Retire at Year-End While Continuing as Vice Chairman 39
Appendix 40
Methodology 40
About GlobalData 40
Contact Us 40
Disclaimer 40
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.